Alkem Executive and Leadership Team

Ravindra Sharma, the Chief Executive Officer at Alkem, directs the overarching corporate strategy and long-term vision for the pharmaceutical enterprise. Sharma oversees the integration of manufacturing capabilities with global market expansion, ensuring that the company maintains a competitive edge in the development of complex nutraceutical products. By aligning departmental goals with the broader mission of delivering accessible healthcare solutions, the Chief Executive Officer fosters a culture of operational excellence across all international divisions. Ravindra Sharma actively engages with the Board to refine capital allocation and prioritize research investments that drive sustainable revenue growth. Through rigorous oversight of the entire value chain, the Chief Executive Officer ensures that Alkem remains a leader in the pharmaceutical sector. This leadership role demands constant vigilance regarding regulatory compliance and market shifts, which Sharma manages by implementing agile decision-making frameworks that support the company's expansive global footprint.

Yugandhara Hiray, the Manager - Strategy and CEO's Chief of Staff at Alkem, coordinates strategic initiatives and facilitates communication between the executive office and various business units. Hiray architects frameworks for organizational efficiency, ensuring that the strategic priorities set by the Chief Executive Officer permeate every level of the pharmaceutical company. By monitoring the execution of key projects, the Manager - Strategy and CEO's Chief of Staff identifies bottlenecks and implements solutions to streamline internal processes. Yugandhara Hiray supports the leadership team by synthesizing complex data into actionable insights that inform corporate decision-making. This role involves managing cross-functional collaborations to ensure alignment with the company's mission of delivering pharmaceutical excellence. Through meticulous planning and project management, the Manager - Strategy and CEO's Chief of Staff drives the successful implementation of growth strategies. Hiray maintains a focus on operational agility, enabling the organization to respond effectively to the evolving demands of the global pharmaceutical market.

Rajesh Dubey, the Chief Financial Officer at Alkem, manages the fiscal health and capital structure of the organization. Dubey directs financial planning, budgeting, and reporting processes to ensure transparency and long-term stability for the pharmaceutical manufacturer. By analyzing market trends and operational costs, the Chief Financial Officer optimizes resource allocation to support the development of new pharmaceutical products. Rajesh Dubey collaborates with executive leadership to evaluate investment opportunities and mitigate financial risks associated with global operations. This role involves maintaining strong relationships with investors and regulatory bodies to uphold the financial integrity of the company. Through the implementation of robust financial controls, the Chief Financial Officer secures the necessary liquidity for ongoing research and manufacturing initiatives. Dubey provides critical insights that guide the strategic direction of the firm, ensuring that every financial decision aligns with the core mission of providing high-quality healthcare solutions to diverse patient populations.

Dishant Doshi, the Vice President, Finance & Head Chief Financial Officer, S Office at Alkem, manages specialized financial operations and supports the executive finance function. Doshi directs the analysis of regional financial performance, ensuring that the company's manufacturing and sales activities remain profitable across diverse markets. By overseeing the financial reporting for specific business segments, the Vice President, Finance & Head Chief Financial Officer, S Office provides the data necessary for strategic resource allocation. Dishant Doshi collaborates with the broader finance team to ensure compliance with international accounting standards and internal fiscal policies. This role involves monitoring cash flow and capital expenditures to support the ongoing development of pharmaceutical and nutraceutical products. Through detailed financial oversight, the Vice President, Finance & Head Chief Financial Officer, S Office contributes to the overall stability and growth of the organization. Doshi ensures that financial operations remain aligned with the company's long-term objectives and market expansion goals.

Nitin Agrawal, the Global Chief Financial Officer at Alkem, oversees the international financial strategy and fiscal governance of the company. Agrawal directs the consolidation of global financial results, ensuring that the pharmaceutical manufacturer maintains a strong balance sheet across all operating regions. By managing currency risks and international tax strategies, the Global Chief Financial Officer optimizes the financial performance of the company's global supply chain. Nitin Agrawal works closely with regional leaders to ensure that financial resources are deployed effectively to capture market share in emerging and established pharmaceutical sectors. This role involves providing high-level financial guidance to the Board and executive team to support long-term investment decisions. Through the implementation of global financial standards, the Global Chief Financial Officer ensures consistency and accountability across the entire organization. Agrawal drives the financial health of the company, enabling the continued development and distribution of essential healthcare products worldwide.

Sunil Pathak, the President, Semi Chronic Business, Oncology, Biosimilar at Alkem, leads the development and commercialization of specialized pharmaceutical product lines. Pathak directs the strategy for oncology and biosimilar portfolios, ensuring that these critical therapies reach patients in need across global markets. By overseeing the research, manufacturing, and marketing of these complex products, the President, Semi Chronic Business, Oncology, Biosimilar drives innovation in the treatment of chronic and semi-chronic conditions. Sunil Pathak collaborates with clinical and regulatory teams to navigate the complexities of bringing advanced therapies to market. This role involves managing the lifecycle of high-value pharmaceutical assets to ensure sustained growth and therapeutic impact. Through the strategic expansion of the oncology and biosimilar divisions, the President, Semi Chronic Business, Oncology, Biosimilar strengthens the company's position as a leader in specialized healthcare. Pathak ensures that these business units remain focused on delivering high-quality, accessible medical solutions to diverse patient populations.

Ak Mishra, the President at Alkem, oversees the operational execution of core manufacturing and distribution functions. Mishra directs the production teams to ensure that pharmaceutical products meet the highest quality standards while maintaining efficient output levels. By managing the supply chain and logistics, the President ensures that the company's products are available to meet global demand. Ak Mishra collaborates with other executive leaders to align manufacturing capabilities with the company's strategic growth objectives. This role involves optimizing production processes to reduce costs and improve the overall reliability of the supply chain. Through the leadership of key operational divisions, the President drives the company's ability to scale its pharmaceutical and nutraceutical offerings. Mishra focuses on maintaining operational excellence and ensuring that all manufacturing activities comply with international regulatory requirements. By fostering a culture of continuous improvement, the President supports the company's mission of providing reliable healthcare solutions to patients worldwide.

Shirish Ambulgekar, the President at Alkem, leads the strategic development of international market presence and business expansion. Ambulgekar directs the efforts to enter new geographic territories, ensuring that the company's pharmaceutical products are successfully introduced to diverse healthcare systems. By analyzing regional market dynamics, the President identifies opportunities for growth and tailors the company's product offerings to meet local needs. Shirish Ambulgekar collaborates with global sales and marketing teams to build brand awareness and establish strong partnerships with healthcare providers. This role involves managing the complexities of international regulatory environments to ensure smooth product registration and distribution. Through the expansion of the company's global footprint, the President drives revenue growth and increases the accessibility of essential medications. Ambulgekar focuses on building sustainable market positions that support the long-term success of the organization. By leveraging deep industry knowledge, the President ensures that the company remains a competitive force in the global pharmaceutical landscape.

Girish Kumar, the President at Alkem, manages the research and development pipeline for new pharmaceutical and nutraceutical products. Kumar directs the scientific teams to ensure that the company remains at the forefront of medical innovation. By overseeing the transition from laboratory research to commercial manufacturing, the President ensures that new therapies are developed efficiently and effectively. Girish Kumar collaborates with regulatory and clinical experts to validate the safety and efficacy of the company's product portfolio. This role involves prioritizing research investments to address unmet medical needs and capitalize on emerging therapeutic trends. Through the leadership of the R&D division, the President drives the creation of high-value products that contribute to the company's growth and market impact. Kumar focuses on fostering a culture of scientific excellence and innovation. By ensuring that the development pipeline remains robust, the President supports the company's mission of delivering advanced healthcare solutions to patients across the globe.

Ramanarayana Parhi, the Vice President & Chief Information Officer at Alkem, leads the digital transformation and technological infrastructure of the pharmaceutical firm. Parhi directs the implementation of advanced data systems that support manufacturing precision and supply chain visibility across global operations. By integrating secure information technology platforms, the Vice President & Chief Information Officer ensures that research and development teams have access to the tools necessary for innovation. Ramanarayana Parhi oversees cybersecurity protocols to protect sensitive intellectual property and patient data, maintaining the highest standards of digital integrity. This leadership role involves collaborating with other executives to leverage technology for improved operational efficiency and market responsiveness. Through the modernization of IT systems, the Vice President & Chief Information Officer enables the company to scale its production capabilities effectively. Parhi drives the adoption of digital solutions that enhance the overall quality and delivery of pharmaceutical products to international markets.